C075-0264 Screening compound: N-[3-(3,5-dimethylpiperidin-1-yl)propyl]-2-{[3-(4-methoxyphenyl)-4-oxo-3,4-dihydrophthalazin-1-yl]formamido}acetamide

C075-0264 Screening compound: N-[3-(3,5-dimethylpiperidin-1-yl)propyl]-2-{[3-(4-methoxyphenyl)-4-oxo-3,4-dihydrophthalazin-1-yl]formamido}acetamide
C075-0264 Screening compound: N-[3-(3,5-dimethylpiperidin-1-yl)propyl]-2-{[3-(4-methoxyphenyl)-4-oxo-3,4-dihydrophthalazin-1-yl]formamido}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C075-0264
N-[3-(3,5-dimethylpiperidin-1-yl)propyl]-2-{[3-(4-methoxyphenyl)-4-oxo-3,4-dihydrophthalazin-1-yl]formamido}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C075-0264

Molecular Formula

C28H35N5O4 (C28 H35 N5 O4)

Compound Name

N-[3-(3,5-dimethylpiperidin-1-yl)propyl]-2-{[3-(4-methoxyphenyl)-4-oxo-3,4-dihydrophthalazin-1-yl]formamido}acetamide

IUPAC name

N-[3-(35-dimethylpiperidin-1-yl)propyl]-2-{[3-(4-methoxyphenyl)-4-oxo-34-dihydrophthalazin-1-yl]formamido}acetamide

SMILES

CC1CN(CCCNC(CNC(C(c2c3cccc2)=NN(c(cc2)ccc2OC)C3=O)=O)=O)CC(C)C1

InChI

InChI=1S/C28H35N5O4/c1-19-15-20(2)18-32(17-19)14-6-13-29-25(34)16-30-27(35)26-23-7-4-5-8-24(23)28(36)33(31-26)21-9-11-22(37-3)12-10-21/h4-5,7-12,19-20H,6,13-18H2,1-3H3,(H,29,34)(H,30,35)

InChI Key

IHJDLPOVTJXFJH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14717783

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

505.62

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.078

Distribution Coefficient, logD

0.474

Water Solubility, LogSw

-3.62

Polar Surface Area

86.167

Acid Dissociation Constant (pKa)

12.09

Base Dissociation Constant (pKb)

10.00

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

42.90

C075-0264 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Anticancer Library (62698 compounds)

Dark Chemical Matter Library (18430 compounds)

Human Proteases Annotated Library (2868 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Pool
Therapeutical areas:
  • Cancer

References: we are preparing a list of scientific research reports with C075-0264 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C075-0264?
Check Price and Availability of C075-0264, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C075-0264 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C075-0264
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C075-0264
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C075-0264 available by request